Ketamine inhibits nitric oxide production in mouse-activated macrophage-like cells

British Journal of Anaesthesia

Volumn 77, Issue 2, 1996, Pages 238-242

  Shimaoka, M ^a   Iida, T ^c   Ohara, A ^b   Taenaka, N ^a   Mashimo, T ^b   Honda, T ^c   Yoshiya, I ^a  

^a OSAKA UNIVERSITY HOSPITAL   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Anaesthetics i.v; Immune response; Ketamine; Model, mouse; Mouse; Pharmacology, nitric oxide; Polypeptides, cytokines

Indexed keywords

DEXTROMETHORPHAN; DIZOCILPINE; GAMMA INTERFERON; KETAMINE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030056572     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/77.2.238     Document Type: Article

References (41)

1. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB Journal 1992; 6: 3051-3064.
2. Nussler AK, Billar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. Journal of Leukocyte Biology 1993; 54: 171-178.
3. Ochoa JB, Udekwu AO, Billar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB. Nitrogen oxide levels in patients after trauma and sepsis. Annals of Surgery 1991; 214: 621-626.
4. Corbett JA, Wang JL, Hughes JH, Wolf BA, Sweetland MA, Lancaster JR jr, McDaniel ML. Nitric oxide and cGMP formation induced by interleukin-1β in Islets of Langerhans : evidence for an effector role of nitric oxide in islet dysfunction. Biochemical Journal 1992; 287: 229-235.
5. Seekamp A, Mulligan MS, Till GO, Ward PA. Requirements for neutrophil products and L-arginine in ischemia-reperfusion injury. American Journal of Pathology 1993; 142: 1217-1226.
6. Fabian RH, Rea HC. Neuronal toxicity by macrophages in mixed brain cell culture is augmented by antineuronal IgG and dependent upon nitric oxide synthesis. Journal of Neuroimmunology 1993; 44: 95-102.
7. Beal MF. Mechanisms of exitotoxicity in neurologic diseases. FASEB Journal 1992; 6: 3338-3344.
8. Peterson PK, Hu S, Anderson R, Chao CC. Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. Journal of Infectious Diseases 1994; 170: 457-460.
9. Rothman SM, Thurston JH, Hauhart RE, Clark GD, Solomon JS. Ketamine protects hippocampal neurons from anoxia in vitro. Neuroscience 1987; 21: 673-678.
10. Chan PK, Chu L. Ketamine protects cultured astrocytes from glutamate-induced swelling. Brain Research 1989; 487: 380-383.
11. Gonzales JM, Loeb AL, Reichard PS, Steven IBS. Ketamine inhibits glutamate-, N-methyl-D-aspartate, and quisqualate-stimulated cGMP production in cultured cerebral neurons. Anesthesiology 1995; 82: 205-213.
12. Fujihara M, Ito N, Pace JL, Watanabe Y, Russell SW, Suzuki T. Role of endogenous interferon-β in lipopolysaccharide-triggered activation of the inducible nitric oxide synthase gene in a mouse macrophage cell line, J774. Journal of Biological Chemistry 1994; 269: 12773-12778.
13. Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. Journal of Experimental Medicine 1993; 178: 605-613.
14. Cenci E, Romani L, Mencacci A, Spaccapelo R, Schiaffella E, Puccetti P, Bistoni F. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. European Journal of Immunology 1993; 23: 1034-1038.
15. Wang MH, Cox GW, Yoshimura T, Sheffler LA, Skeel A, Leonard EJ. Macrophage-stimulating protein inhibits induction of nitric oxide production by endotoxin- or cytokine-stimulated mouse macrophages. Journal of Biological Chemistry 1994; 269: 14027-14031.
16. Drobyski WR, Keever CA, Hanson GA, McAuliffe T, Griffith OW. Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versushost disease after bone marrow transplantation. Blood 1994; 84: 2363-2373.
17. Florquin S, Amraoui Z, Dubois C, Decuyper J, Goldman M. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. Journal of Experimental Medicine 1994; 180: 1153-1158.
18. Stuehr DJ, Nathan CE. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. Journal of Experimental Medicine 1989; 169: 1543-1555.
19. Cunha FQ, Moss DW, Leal LMCC, Moncada S, Liew FY. Induction of macrophage parasiticidal activity by Staphylococcus aureus and exotoxins through the nitric oxide synthesis pathway. Immunology 1993; 78: 563-567.
20. Moncada S, Palmar RM, Higgs EA, Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 1991; 43: 109-115.
21. Huang JC, Salt TE, Voaden MJ, Marshall J. Non-competitive NMDA-receptor antagonists and anoxic degeneration of the ERG B-wave in vitro. Eye 1991; 5: 476-480.
22. Trube G, Netzer R. Dextromethorphan : cellular effects reducing neuronal hyperactivity. Epilepsia 1994; 35 (Suppl.): S62-S67.
23. Mathison JC, Wolfson E, Ulevitch RJ. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. Journal of Clinical Investigation 1988; 81: 1925-1937.
24. Oswald IP, Wynn T, Sher A, James SL. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor α required as a costimulatory factor for interferon γ-induced activation. Proceedings of the National Academy of Sciences USA 1992; 89: 8676-8680.
25. Krumholz W, Hempelmann G. Propofol inhibits phagocytosis and killing of Staphylococcus aureus and Esherichia coli by polymorphonuclear leucocytes in vitro. Canadian Journal of Anaesthesia 1994; 41: 446-449.
26. Takenaka I, Ogata M, Koga K, Matsumoto T, Shigematsu A. Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice. Anesthesiology 1994; 80: 402-408.
27. Beat AL, Cerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory responses and organ dysfunction. Journal of the American Medical Association 1994; 271: 226-233.
28. Rinaldo JE, Rogers RM. Adult respiratory distress syndrome, changing concepts of lung injury and repair. New England Journal of Medicine 1982; 206: 900-909.
29. Weiss SJ. Tissue destruction by neutrophil. New England Journal of Medicine 1989; 320: 365-376.
30. Guilan D, Robertson C. Inhibition of mononuclear phagocytes reduces ischemie injury in the spinal cord. Annals of Neurology 1990; 27: 33-42.
31. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S. Macrophage deactivating factor and transforming growth factor-β1, -β2, -β2 inhibit induction of macrophage nitrogen oxide syntheses by IFN-γ. Journal of Immunology 1990; 145: 940-944.
32. Garthwaite J, Charles SL, Chess-Williams R. Endotheliumderived relaxing factor release on activation of NMDA receptor suggests role as intercellular messenger in the brain. Nature (London) 1988; 336: 385-388.
33. Piani D, Spranger M, Frei K, Schaffher, A, Fontana A. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurones involves excitatory amino acid rather than reactive oxygen intermediates and cytokines. European Journal of Immunology 1992; 22: 2429-2436.
34. Coffey PJ, Perry VH, Rawlins JNP. An investigation into the early stages of the inflammatory response following ibotenic acid-induced neuronal degeneration. Neuroscience 1990; 35: 121-132.
35. Church J, Zeman S, Lodge D. The neuroprotective action of ketamine and MK-801 after transient cerebral ischemia in rats. Anesthesiology 1988; 69: 702-709.
36. Marcoux FW, Goodrich JE, Dominick MA. Ketamine prevents ischemic neuronal injury. Brain Research 1988; 452: 329-335.
37. Corradin SB, Heumann D, Gallay P, Smith J, Mauel J, Glauser MP. Bactericidal/permeability-increasing protein inhibits induction of macrophage nitric oxide production by lipopolysaccharide. Journal of Infectious Diseases 1994; 169: 105-111.
38. Muri WW, Sams R. Effects of ketamine infusion on halothane minimal alveolar concentration in horse. American Journal of Veterinary Research 1992; 53: 1802-1806.
39. Schwieger IM, Szlam F, Hug CC jr. The pharmacokinetics of ketamine in dogs anesthetized with enflurane. Journal of Pharmacokinetics and Biopharmacology 1991; 19: 145-156.
40. Hartvig P, Larsson E, Joachimmsson PO. Postoperative analgesia and sedation following pediatric cardiac surgery using a constant infusion of ketamine. Journal of Cardiothoracic and Vascular Anesthesia 1993; 7: 148-153.
41. Chang T, Glazko AJ. A gas Chromatographic assay for ketamine in human plasma. Anesthesiology 1972; 36:401-404.